General MedicationsORALStandard
POSACONAZOLE
POSACONAZOLE
Standard Dose
40MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview POSACONAZOLE is listed in Drugs@FDA under application 208773 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient POSACONAZOLE Form and strength SUSPENSION;ORAL - 40MG/ML Sponsor HIKMA Submission history Latest submission status date: 2024-10-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview POSACONAZOLE is listed in Drugs@FDA under application 208773 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient POSACONAZOLE Form and strength SUSPENSION;ORAL - 40MG/ML Sponsor HIKMA Submission history Latest submission status date: 2024-10-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.